Sources | Names Used |
---|---|
CTRPv2 | Repligen 136 |
PharmacoGx | Repligen 136 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYO16 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | GBGT1 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | APOL4 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | RP11-1212A22.4 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-07 |
mRNA | HNRNPA1 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-07 |
mRNA | CD69 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | GAB2 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | DNMT3A | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
mRNA | MED24 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | ELF2 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |